SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001358403-16-000193
Filing Date
2016-05-18
Accepted
2016-05-18 07:03:06
Documents
4
Period of Report
2016-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K q12016form8-knewdirector.htm 8-K 36058
2 EXHIBIT 99.1 q12016pressreleasenewdirec.htm EX-99.1 11774
3 COMPANY LOGO companylogoimage1.jpg GRAPHIC 50539
4 q12016pressreleasenew_image2.gif GRAPHIC 43
  Complete submission text file 0001358403-16-000193.txt   119098
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 161659412
SIC: 2834 Pharmaceutical Preparations